![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RP Irwin, SZ Lin, MA Rogawski, RH Purdy and SM Paul
Section on Molecular Pharmacology, National Institute of Mental Health, Bethesda, Maryland.
Pregnenolone sulfate and 15 related steroids were investigated for their effects on N-methyl-D-aspartate (NMDA)-induced elevations in intracellular Ca++ ([Ca++]i) in cultured rat hippocampal neurons by microspectrofluorimetry with the Ca(++)-sensitive indicator fura-2. Several pregn-5-ene steroids markedly potentiated NMDA-mediated [Ca++]i responses. Pregnenolone sulfate and its 21-acetoxy derivative and pregnenolone hemisuccinate were the most active. At a concentration of 50 microM, each produced approximately 300% potentiation of 5 microM NMDA responses. In addition, several steroids were identified that inhibited NMDA-induced elevations in [Ca++]i, the most potent of which was 3 alpha-hydroxy-5 beta-pregnan-20-one sulfate (IC50, 37 microM). Concentration-response curves for NMDA in the presence of active steroids revealed noncompetitive interaction(s) of these steroids with the NMDA receptor. Although the mechanism(s) responsible for either steroid-induced augmentation or inhibition of NMDA-receptor responses is unknown, these data suggest the presence of one or more steroid recognition sites with a high degree of structural specificity associated with NMDA receptors. These results further raise the possibility that pregn-5-ene 3-sulfates and pregnane 3-sulfates could be endogenous modulators of NMDA receptor-mediated synaptic events.
This article has been cited by other articles:
|
|
 |
|
  L. Stoll, J. Hall, N. Van Buren, A. Hall, L. Knight, A. Morgan, S. Zuger, H. Van Deusen, and L. Gentile Differential Regulation of Ionotropic Glutamate Receptors Biophys. J., February 15, 2007; 92(4): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Rasgon and L. Jarvik Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2004; 59(2): M178 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Urani, F. J. Roman, V.-L. Phan, T.-P. Su, and T. Maurice The Antidepressant-Like Effect Induced by sigma 1-Receptor Agonists and Neuroactive Steroids in Mice Submitted to the Forced Swimming Test J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1269 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Bowen, R. H. Purdy, and K. A. Grant Ethanol-Like Discriminative Stimulus Effects of Endogenous Neuroactive Steroids: Effect of Ethanol Training Dose and Dosing Procedure J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 405 - 411. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Park-Chung, F.-S. Wu, R. H. Purdy, A. A. Malayev, T. T. Gibbs, and D. H. Farb Distinct Sites for Inverse Modulation of N-Methyl-D-Aspartate Receptors by Sulfated Steroids Mol. Pharmacol., December 1, 1997; 52(6): 1113 - 1123. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. E. Weaver Jr., P. Marek, M. Park-Chung, S. W. Tam, and D. H. Farb Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor PNAS, September 16, 1997; 94(19): 10450 - 10454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gasior, R. B. Carter, S. R. Goldberg, and J. M. Witkin Anticonvulsant and Behavioral Effects of Neuroactive Steroids Alone and in Conjunction with Diazepam J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 543 - 553. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
